| UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C.  20549                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  FORM 10-Q                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|  For the quarterly period ended October 31, 2009 OR  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number 1-5865                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Gerber Scientific, Inc.(Exact name of registrant as specified in its charter)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Connecticut                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 06-0640743 |
| (State or other jurisdiction of incorporation or organization)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | (I.R.S. Employer Identification No.) |
| 83 Gerber Road West, South Windsor, Connecticut(Address of principal executive offices)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 06074(Zip Code) |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Registrant's telephone number, including area code:  (860) 644-1551                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90days.  Yes þ    No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|  Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was requiredto submit and post such files).  Yes    No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.Large accelerated filer                                                                                Acceleratedfiler þ                               Non-accelerated filer  (Do not check if a smaller reporting company)       Smaller reporting company     |
| Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes     No þ                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 25,213,728 shares of common stock of the registrant were outstanding as of November 30, 2009, exclusive of treasury shares.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |   |   |   |

----

|          | GERBER SCIENTIFIC, INC.Index to Quarterly Reporton Form 10-QFiscal Quarter Ended October 31, 2009 |   |
|---------------|---------------------------------------------------------------------------------------------------|--------|
| PART I        | PAGE                                                                                              |
|          |                                                                                              |   |
| Item 1.       | Financial Statements                                                                              |   |
|          | Condensed Consolidated Statements of Operations                                                   | 3-4    |
|          | Condensed Consolidated Balance Sheets                                                             | 5      |
|          | Condensed Consolidated Statements of Cash Flows                                                   | 6      |
|          | Notes to Condensed Consolidated Financial Statements                                              | 7-16   |
| Item 2        | Management's Discussion and Analysis of Financial Condition and Results of Operations             | 17-28  |
| Item 3.       | Quantitative and Qualitative Disclosures about Market Risk                                        | 29     |
| Item 4.       | Controls and Procedures                                                                           | 29     |
|          |                                                                                              |   |
| PART II       |                                                                                              |
|          |                                                                                              |   |
| Item 1A.      | Risk Factors                                                                                      | 30     |
| Item 2.       | Unregistered Sales of Equity Securities and Use of Proceeds                                       | 30     |
| Item 4.       | Submission of Matters to a Vote of Security Holders                                               | 30-31  |
| Item 5.       | Other information                                                                                 | 31-32  |
| Item 6.       | Exhibits                                                                                          | 33     |
|          |                                                                                              |   |
| Signature     | 34                                                                                                |
| Exhibit Index | 35                                                                                                |

----

PART I – FINANCIAL INFORMATION

ITEM 1.    FINANCIAL STATEMENTS

Condensed Consolidated Statements of Operations

|                                                                            | For the Fiscal Quarters Ended October 31, |   |
|---------------------------------------------------------------------------------|-------------------------------------------|--------|
| In thousands, except per share data                                             |                                      | 2009   |   |   | 2008 |   |
| Revenue:                                                                        |                                      |   |   |   |   |   |
|      Product sales                                     |                                      | $      | 103,546 |   |   | $ | 123,760 |   |
|      Service sales                                     |                                      |   | 16,614 |   |   |   | 18,793 |   |
|                                                                            |                                      |   | 120,160 |   |   |   | 142,553 |   |
| Cost of Sales:                                                                  |                                      |   |   |   |   |   |   |   |
|      Cost of products sold                             |                                      |   | 74,646 |   |   |   | 88,811 |   |
|      Cost of services sold                             |                                      |   | 10,294 |   |   |   | 12,337 |   |
|                                                                            |                                      |   | 84,940 |   |   |   | 101,148 |   |
|                                                                            |                                      |   |   |   |   |   |   |   |
| Gross profit                                                                    |                                      |   | 35,220 |   |   |   | 41,405 |   |
|                                                                            |                                      |   |   |   |   |   |   |   |
| Selling, general and administrative expenses                                    |                                      |   | 27,817 |   |   |   | 30,155 |   |
| Research and development                                                        |                                      |   | 4,532 |   |   |   | 5,698 |   |
| Operating income                                                                |                                      |   | 2,871 |   |   |   | 5,552 |   |
|                                                                            |                                      |   |   |   |   |   |   |   |
| Other income (expense), net                                                     |                                      |   | (394 | ) |   |   | (412 | ) |
| Interest expense                                                                |                                      |   | (918 | ) |   |   | (748 | ) |
| Income from continuing operations before income taxes                           |                                      |   | 1,559 |   |   |   | 4,392 |   |
| Income tax benefit                                                              |                                      |   | (374 | ) |   |   | (1,973 | ) |
| Income from continuing operations                                               |                                      |   | 1,933 |   |   |   | 6,365 |   |
| Loss from discontinued operations, net of taxes of ($971) and $13, respectively | (1,474                                    | )      |   |   | (271 | ) |
| Net income                                                                      |                                      | $      | 459 |   |   | $ | 6,094 |   |
|                                                                            |                                      |   |   |   |   |   |   |   |
| Basic earnings (loss) per common share:                                         |                                      |   |   |   |   |   |   |   |
|   Continuing operations                                               |                                      | $      | 0.08 |   |   | $ | 0.27 |   |
|   Discontinued operations                                             |                                      |   | (0.06 | ) |   |   | (0.02 | ) |
| Basic earnings per common share                                                 |                                      | $      | 0.02 |   |   | $ | 0.25 |   |
| Diluted earnings (loss) per common share:                                       |                                      |   |   |   |   |   |   |   |
|   Continuing operations                                               |                                      | $      | 0.08 |   |   | $ | 0.26 |   |
|   Discontinued operations                                             |                                      |   | (0.06 | ) |   |   | (0.01 | ) |
| Diluted earnings per common share                                               |                                      | $      | 0.02 |   |   | $ | 0.25 |   |
|                                                                            |                                      |   |   |   |   |   |   |   |
| Weighted Average Common Shares Outstanding:                                     |                                      |   |   |   |   |   |   |   |
|   Basic                                                               |                                      |   | 24,907 |   |   |   | 23,965 |   |
|   Diluted                                                             |                                      |   | 24,956 |   |   |   | 24,087 |   |

----

|                                                                            | For the Six Months Ended October 31, |   |
|---------------------------------------------------------------------------------|--------------------------------------|--------|
| In thousands, except per share data                                             |                                 | 2009   |   |   | 2008 |   |
| Revenue:                                                                        |                                 |   |   |   |   |   |
|      Product sales                                     |                                 | $      | 197,310 |   |   | $ | 252,950 |   |
|      Service sales                                     |                                 |   | 33,438 |   |   |   | 37,768 |   |
|                                                                            |                                 |   | 230,748 |   |   |   | 290,718 |   |
| Cost of Sales:                                                                  |                                 |   |   |   |   |   |   |   |
|      Cost of products sold                             |                                 |   | 143,430 |   |   |   | 183,624 |   |
|      Cost of services sold                             |                                 |   | 20,071 |   |   |   | 25,345 |   |
|                                                                            |                                 |   | 163,501 |   |   |   | 208,969 |   |
|                                                                            |                                 |   |   |   |   |   |   |   |
| Gross profit                                                                    |                                 |   | 67,247 |   |   |   | 81,749 |   |
|                                                                            |                                 |   |   |   |   |   |   |   |
| Selling, general and administrative expenses                                    |                                 |   | 51,967 |   |   |   | 62,718 |   |
| Research and development                                                        |                                 |   | 8,960 |   |   |   | 11,931 |   |
| Operating income                                                                |                                 |   | 6,320 |   |   |   | 7,100 |   |
|                                                                            |                                 |   |   |   |   |   |   |   |
| Other income (expense), net                                                     |                                 |   | (1,399 | ) |   |   | (537 | ) |
| Interest expense                                                                |                                 |   | (1,860 | ) |   |   | (1,287 | ) |
| Income from continuing operations before income taxes                           |                                 |   | 3,061 |   |   |   | 5,276 |   |
| Income tax benefit                                                              |                                 |   | (15 | ) |   |   | (1,813 | ) |
| Income from continuing operations                                               |                                 |   | 3,076 |   |   |   | 7,089 |   |
| Loss from discontinued operations, net of taxes of ($891) and $30, respectively | (2,103                               | )      |   |   | (314 | ) |
| Net income                                                                      |                                 | $      | 973 |   |   | $ | 6,775 |   |
|                                                                            |                                 |   |   |   |   |   |   |   |
| Basic earnings (loss) per common share:                                         |                                 |   |   |   |   |   |   |   |
|   Continuing operations                                               |                                 | $      | 0.12 |   |   | $ | 0.30 |   |
|   Discontinued operations                                             |                                 |   | (0.08 | ) |   |   | (0.02 | ) |
| Basic earnings per common share                                                 |                                 | $      | 0.04 |   |   | $ | 0.28 |   |
| Diluted earnings (loss) per common share:                                       |                                 |   |   |   |   |   |   |   |
|   Continuing operations                                               |                                 | $      | 0.12 |   |   | $ | 0.29 |   |
|   Discontinued operations                                             |                                 |   | (0.08 | ) |   |   | (0.01 | ) |
| Diluted earnings per common share                                               |                                 | $      | 0.04 |   |   | $ | 0.28 |   |
|                                                                            |                                 |   |   |   |   |   |   |   |
| Weighted Average Common Shares Outstanding:                                     |                                 |   |   |   |   |   |   |   |
|   Basic                                                               |                                 |   | 24,759 |   |   |   | 23,865 |   |
|   Diluted                                                             |                                 |   | 24,782 |   |   |   | 24,047 |   |

----

Condensed Consolidated Balance Sheets

|                                                                       |   | October 31, |    |   | April 30, |   |
|----------------------------------------------------------------------------|--------|-------------|---------|--------|-----------|--------|
| In thousands                                                               |   | 2009        |    |   | 2009      |   |
| Assets:                                                                    |   |        |    |   |      |   |
| Current Assets:                                                            |   |        |    |   |      |   |
|      Cash and cash equivalents                    |   | $           | 14,443  |   |      | $      | 10,313 |   |
|      Accounts receivable, net                     |   |        | 84,122  |   |      |   | 87,798 |   |
|      Inventories                                  |   |        | 64,065  |   |      |   | 72,108 |   |
|      Deferred tax assets, net                     |   |        | 10,016  |   |      |   | 9,022 |   |
|      Prepaid expenses and other current assets    |   |        | 6,922   |   |      |   | 4,659 |   |
|         Total Current Assets       |   |        | 179,568 |   |      |   | 183,900 |   |
| Property, plant and equipment, net                                         |   |        | 34,554  |   |      |   | 37,119 |   |
| Goodwill                                                                   |   |        | 81,143  |   |      |   | 76,940 |   |
| Deferred tax assets, net                                                   |   |        | 44,144  |   |      |   | 43,339 |   |
| Other assets                                                               |   |        | 17,649  |   |      |   | 17,919 |   |
|         Total Assets               |   | $           | 357,058 |   |      | $      | 359,217 |   |
| Liabilities and Shareholders' Equity:                                      |   |        |    |   |      |   |   |   |
| Current Liabilities:                                                       |   |        |    |   |      |   |   |   |
|      Accounts payable                             |   | $           | 41,554  |   |      | $      | 37,494 |   |
|      Accrued compensation and benefits            |   |        | 14,851  |   |      |   | 15,735 |   |
|      Other accrued liabilities                    |   |        | 23,365  |   |      |   | 24,748 |   |
|      Deferred revenue                             |   |        | 11,990  |   |      |   | 13,084 |   |
|         Total Current Liabilities  |   |        | 91,760  |   |      |   | 91,061 |   |
| Long-term debt                                                             |   |        | 51,000  |   |      |   | 73,500 |   |
| Accrued pension benefit liability                                          |   |        | 30,121  |   |      |   | 29,629 |   |
| Other long-term liabilities                                                |   |        | 17,362  |   |      |   | 16,725 |   |
|                                                                       |   |        |    |   |      |   |   |   |
| Commitments and contingencies                                              |   |        |    |   |      |   |   |   |
|  Shareholders' Equity:                                                |   |        |    |   |      |   |   |   |
|      Preferred stock                              |   |        | ---     |   |      |   | --- |   |
|      Common stock                                 |   |        | 258     |   |      |   | 252 |   |
|      Paid-in capital                              |   |        | 80,625  |   |      |   | 79,198 |   |
|      Retained earnings                            |   |        | 98,635  |   |      |   | 97,662 |   |
|      Treasury stock                               |   |        | (11,214 | )      |      |   | (11,531 | ) |
|      Accumulated other comprehensive loss         |   |        | (1,489  | )      |      |   | (17,279 | )  |
|         Total Shareholders' Equity |   |        | 166,815 |   |      |   | 148,302 |   |
| Total Liabilities and Shareholders' Equity                                 |   | $           | 357,058 |   |      | $      | 359,217 |   |

----

Condensed Consolidated Statements of Cash Flows

|                                                                                                                   | For the Six Months Ended October 31, |   |
|------------------------------------------------------------------------------------------------------------------------|--------------------------------------|--------|
| In thousands                                                                                                           |                                 | 2009   |   |   | 2008 |   |
| Cash flows from operating activities:                                                                                  |                                 |   |   |   |   |   |
|  Net income                                                                                                       |                                 | $      | 973 |   |   | $ | 6,775 |   |
| Adjustments to reconcile net income to cash provided byoperating activities:                                      |                                 |   |   |   |   |   |   |   |
|        Depreciation and amortization                                                |                                 |   | 5,144 |   |   |   | 4,826 |   |
|        Deferred income taxes                                                        |                                 |   | (1,435 | ) |   |   | (2,376 | ) |
|        Stock-based compensation                                                     |                                 |   | 1,796 |   |   |   | 1,422 |   |
|        Loss (gain) on sale of assets                                                |                                 |   | 2,168 |   |   |   | (622 | ) |
|        Other noncash items                                                          |                                 |   | 670 |   |   |   | 578 |   |
|        Changes in operating accounts, excluding effects of acquisitions:            |                                 |   |   |   |   |   |   |   |
|             Accounts receivable                            |                                 |   | 4,396 |   |   |   | 9,938 |   |
|             Inventories                                    |                                 |   | 4,056 |   |   |   | (3,724 | ) |
|             Prepaid expenses and other assets              |                                 |   | (1,208 | ) |   |   | (851 | ) |
|             Accounts payable and other accrued liabilities |                                 |   | 849 |   |   |   | (9,702 | ) |
|             Accrued compensation and benefits              |                                 |   | (1,655 | ) |   |   | (3,323 | ) |
| Net cash provided by operating activities                                                                              |                                 |   | 15,754 |   |   |   | 2,941 |   |
| Cash flows from investing activities:                                                                                  |                                 |   |   |   |   |   |   |   |
|    Capital expenditures                                                                                 |                                 |   | (1,992 | ) |   |   | (4,921 | ) |
|    Proceeds from sale of net assets                                                                     |                                 |   | 13,040 |   |   |   | 1,369 |   |
|    Proceeds from sale of available for sale investments                                                 |                                 |   | 3 |   |   |   | 612 |   |
|    Purchases of available for sale investments                                                          |                                 |   | (42 | ) |   |   | (363 | ) |
|    Business acquisitions                                                                                |                                 |   | (1,461 | ) |   |   | (34,273 | ) |
|    Investments in intangible assets                                                                     |                                 |   | (1,049 | ) |   |   | (505 | ) |
| Net cash provided by (used for) investing activities                                                                   |                                 |   | 8,499 |   |   |   | (38,081 | ) |
| Cash flows from financing activities:                                                                                  |                                 |   |   |   |   |   |   |   |
|    Debt repayments                                                                                      |                                 |   | (63,815 | ) |   |   | (23,271 | ) |
|    Debt proceeds                                                                                        |                                 |   | 41,878 |   |   |   | 64,000 |   |
|    Common stock activity                                                                                |                                 |   | (113 | ) |   |   | 908 |   |
| Net cash (used for) provided by financing activities                                                                   |                                 |   | (22,050 | ) |   |   | 41,637 |   |
| Effect of exchange rate changes on cash                                                                                |                                 |   | 1,927 |   |   |   | (3,988 | ) |
| Increase in cash and cash equivalents                                                                                  |                                 |   | 4,130 |   |   |   | 2,509 |   |
| Cash and cash equivalents at beginning of period                                                                       |                                 |   | 10,313 |   |   |   | 13,892 |   |
| Cash and cash equivalents at end of period                                                                             |                                 | $      | 14,443 |   |   | $ | 16,401 |   |

----

Notes to Condensed Consolidated Financial Statements

----

|                                                              |   | October 31, |   |   | April 30, |   |
|-------------------------------------------------------------------|--------|-------------|--------|--------|-----------|--------|
| In thousands                                                      |   | 2009        |   |   | 2009      |   |
| Raw materials and purchased parts                                 |   | $           | 52,313 |   |      | $      | 58,779 |   |
| Work in process                                                   |   |        | 1,803  |   |      |   | 3,510 |   |
| Finished goods                                                    |   |        | 9,949  |   |      |   | 9,819 |   |
|         Total inventories |   | $           | 64,065 |   |      | $      | 72,108 |   |

|                                                                              |   | October 31, 2009    |   |   | April 30, 2009          |   |
|-----------------------------------------------------------------------------------|--------|---------------------|--------|--------|-------------------------|--------|
|   In thousands                                                          |   | GrossCarryingAmount |   |   | AccumulatedAmortization |   |   | GrossCarryingAmount |   |   | AccumulatedAmortization |   |
| Amortized intangible assets:                                                      |   |                |   |   |                    |   |   |   |   |   |   |   |
|    Patents                                                         |   | $                   | 8,305  |   |                    | $      | 3,484 |   |   | $ | 7,603 |   |   | $ | 3,210 |   |
|    Other                                                           |   |                | 5,261  |   |                    |   | 812 |   |   |   | 5,131 |   |   |   | 739 |   |
|         Total amortized intangible assets |   | $                   | 13,566 |   |                    | $      | 4,296 |   |   | $ | 12,734 |   |   | $ | 3,949 |   |

|   In thousands        |   | Sign Making and Specialty Graphics |   |    | Apparel andFlexibleMaterials |   |   | OphthalmicLensProcessing |   |   | Total  |   |
|---------------------------------|--------|----------------------------------------------|--------|---------|------------------------------|--------|--------|--------------------------|--------|--------|--------|--------|
| Balance as of April 30, 2009    |   | $                                            | 25,737 |    |                         | $      | 34,207 |                     |   | $      | 16,996 |   |   | $ | 76,940 |   |
| Business acquisitions           |   |                                         | 1,086  |    |                         |   | 1,677  |                     |   |   | ---    |   |   |   | 2,763 |   |
| Business dispositions           |   |                                         | (972   | )  |                         |   | (1,581 | )                   |   |   | ---    |   |   |   | (2,553 | ) |
| Effects of currency translation |   |                                         | 2,493  |    |                         |   | 1,500  |                     |   |   | --     |   |   |   | 3,993 |   |
| Balance as of October 31, 2009  |   | $                                            | 28,344 |    |                         | $      | 35,803 |                     |   | $      | 16,996 |   |   | $ | 81,143 |   |

----

|                                                                                      |   | For the Fiscal QuartersEnded October 31, |    |   | For the Six MonthsEnded October 31, |   |
|-------------------------------------------------------------------------------------------|--------|------------------------------------------|---------|--------|-------------------------------------|--------|
|  In thousands                                                                        |   | 2009                                     |    |   | 2008                                |   |   | 2009 |   |   | 2008 |   |
| Sign Making and Specialty Graphics:                                                       |   |                                     |    |   |                                |   |   |   |   |   |   |   |
|   Gerber Scientific Products                                                    |   | $                                        | 13,375  |   |                                | $      | 18,954 |   |   | $ | 24,262 |   |   | $ | 33,519 |   |
|   Spandex                                                                       |   |                                     | 55,689  |   |                                |   | 62,581 |   |   |   | 108,827 |   |   |   | 131,692 |   |
| Sign Making and Specialty Graphics                                                        |   |                                     | 69,064  |   |                                |   | 81,535 |   |   |   | 133,089 |   |   |   | 165,211 |   |
| Apparel and Flexible Materials                                                            |   |                                     | 37,094  |   |                                |   | 45,382 |   |   |   | 72,154 |   |   |   | 94,331 |   |
| Ophthalmic Lens Processing                                                                |   |                                     | 14,002  |   |                                |   | 15,636 |   |   |   | 25,505 |   |   |   | 31,176 |   |
|           Consolidated revenue          |   | $                                        | 120,160 |   |                                | $      | 142,553 |   |   | $  | 230,748 |   |   | $  | 290,718 |   |
|                                                                                      |   |                                     |    |   |                                |   |   |   |   |   |   |   |   |   |   |   |
| Sign Making and Specialty Graphics:                                                       |   |                                     |    |   |                                |   |   |   |   |   |   |   |   |   |   |   |
|   Gerber Scientific Products                                                    |   | $                                        | (1,240  | )      |                                | $      | 150 |   |   | $ | (2,462 | ) |   | $ | (1,215 | ) |
|   Spandex                                                                       |   |                                     | 3,492   |   |                                |   | 2,675 |   |   |   | 6,525 |   |   |   | 6,128 |   |
| Sign Making and Specialty Graphics                                                        |   |                                     | 2,252   |   |                                |   | 2,825 |   |   |   | 4,063 |   |   |   | 4,913 |   |
| Apparel and Flexible Materials                                                            |   |                                     | 3,298   |   |                                |   | 4,929 |   |   |   | 7,457 |   |   |   | 8,595 |   |
| Ophthalmic Lens Processing                                                                |   |                                     | 1,625   |   |                                |   | 1,773 |   |   |   | 2,320 |   |   |   | 1,888 |   |
|         Segment operating income                  |   |                                     | 7,175   |   |                                |   | 9,527 |   |   |   | 13,840 |   |   |   | 15,396 |   |
| Corporate operating expenses                                                              |   |                                     | (4,304  | )      |                                |   | (3,975 | ) |   |   | (7,520 | ) |   |   | (8,296 | ) |
|           Consolidated operating income |   | $                                        | 2,871   |   |                                | $      | 5,552 |   |   | $ | 6,320 |   |   | $ | 7,100 |   |

|                                                                          |   | For the Fiscal QuartersEnded October 31, |   |   | For the Six MonthsEnded October 31, |   |
|-------------------------------------------------------------------------------|--------|------------------------------------------|--------|--------|-------------------------------------|--------|
|  In thousands                                                            |   | 2009                                     |   |   | 2008                                |   |   | 2009 |   |   | 2008 |   |
| Net income                                                                    |   | $                                        | 459    |   |                                | $      | 6,094 |   |   | $ | 973 |   |   | $ | 6,775 |   |
|                                                                          |   |                                     |   |   |                                |   |   |   |   |   |   |   |   |   |   |   |
| Other comprehensive income (loss):                                            |   |                                     |   |   |                                |   |   |   |   |   |   |   |   |   |   |   |
|     Foreign currency translation adjustments              |   |                                     | 2,573  |   |                                |   | (26,963 | ) |   |   | 15,111 |   |   |   | (27,589 | ) |
|     Defined benefit pension plans activity, net of tax    |   |                                     | 96     |   |                                |   | 205 |   |   |   | 192 |   |   |   | 410 |   |
|     Unrealized investment gain (loss) income, net of tax  |   |                                     | 114    |   |                                |   | (593 | ) |   |   | 371 |   |   |   | (809 | ) |
|     Net gain (loss) on derivative instruments, net of tax |   |                                     | 71     |   |                                |   | (147 | ) |   |   | 116 |   |   |   | (127 | ) |
| Total comprehensive income (loss)                                             |   | $                                        | 3,313  |   |                                | $      | (21,404 | ) |   | $  | 16,763 |   |   | $  | (21,340 | ) |

----

|                                              |   | For the Fiscal Quarters Ended October 31, |   |
|---------------------------------------------------|--------|-------------------------------------------|--------|
|                                              |   | 2009                                      |   |   | 2008 |   |
|  In thousands, except per share amounts      |   | NetIncome                                 |   |   | AverageShares |   |   | PerShare |   |   | NetIncome |   |   | AverageShares |   |   | PerShare |   |
| Basic earnings (loss) per common share:           |   |                                      |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|   Continuing operations                 |   | $                                         | 1,933  |   |   |   | 24,907 |   |   | $ | 0.08 |   |   | $ | 6,365 |   |   |   | 23,965 |   |   | $ | 0.27 |   |
|   Discontinued operations               |   | $                                         | (1,474 | ) |   |   | 24,907 |   |   | $ | (0.06 | ) |   |   | (271 | ) |   |   | 23,965 |   |   |   | (0.02 | ) |
| Basic earnings per common share                   |   | $                                         | 459    |   |   |   | 24,907 |   |   | $ | 0.02 |   |   | $ | 6,094 |   |   |   | 23,965 |   |   | $ | 0.25 |   |
|                                              |   |                                      |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Dilutedearnings (loss) per common share:          |   |                                      |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|   Continuing operations                 |   | $                                         | 1,933  |   |   |   | 24,907 |   |   | $ | 0.08 |   |   | $ | 6,365 |   |   |   | 23,965 |   |   | $ | 0.27 |   |
|   Effect of dilutive options and awards |   |                                      | ---    |   |   |   | 49 |   |   |   | --- |   |   |   | --- |   |   |   | 122 |   |   |   | (0.01 | ) |
|   Continuing operations                 |   | $                                         | 1,933  |   |   |   | 24,956 |   |   | $ | 0.08 |   |   | $ | 6,365 |   |   |   | 24,087 |   |   | $ | 0.26 |   |
|   Discontinued operations               |   | $                                         | (1,474 | ) |   |   | 24,956 |   |   | $ | (0.06 | ) |   |   | (271 | ) |   |   | 24,087 |   |   |   | (0.01 | ) |
| Diluted earnings per common share                 |   | $                                         | 459    |   |   |   | 24,956 |   |   | $ | 0.02 |   |   | $ | 6,094 |   |   |   | 24,087 |   |   | $ | 0.25 |   |

|                                              |   | For the Six Months Ended October 31, |   |
|---------------------------------------------------|--------|--------------------------------------|--------|
|                                              |   | 2009                                 |   |   | 2008 |   |
|  In thousands, except per share amounts      |   | NetIncome                            |   |   | AverageShares |   |   | PerShare |   |   | NetIncome |   |   | AverageShares |   |   | PerShare |   |
| Basic earnings (loss) per common share:           |   |                                 |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|   Continuing operations                 |   | $                                    | 3,076  |   |   |   | 24,759 |   |   | $ | 0.12 |   |   | $ | 7,089 |   |   |   | 23,865 |   |   | $ | 0.30 |   |
|   Discontinued operations               |   | $                                    | (2,103 | ) |   |   | 24,759 |   |   | $ | (0.08 | ) |   |   | (314 | ) |   |   | 23,865 |   |   |   | (0.02 | ) |
| Basic earnings per common share                   |   | $                                    | 973    |   |   |   | 24,759 |   |   | $ | 0.04 |   |   | $ | 6,775 |   |   |   | 23,865 |   |   | $ | 0.28 |   |
|                                              |   |                                 |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Dilutedearnings (loss) per common share:          |   |                                 |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|   Continuing operations                 |   | $                                    | 3,076  |   |   |   | 24,759 |   |   | $ | 0.12 |   |   | $ | 7,089 |   |   |   | 23,865 |   |   | $ | 0.30 |   |
|   Effect of dilutive options and awards |   |                                 | ---    |   |   |   | 23 |   |   |   | --- |   |   |   | --- |   |   |   | 182 |   |   |   | (0.01 | ) |
|   Continuing operations                 |   | $                                    | 3,076  |   |   |   | 24,782 |   |   | $ | 0.12 |   |   | $ | 7,089 |   |   |   | 24,047 |   |   | $ | 0.29 |   |
|   Discontinued operations               |   | $                                    | (2,103 | ) |   |   | 24,782 |   |   | $ | (0.08 | ) |   |   | (314 | ) |   |   | 24,047 |   |   |   | (0.01 | ) |
| Diluted earnings per common share                 |   | $                                    | 973    |   |   |   | 24,782 |   |   | $ | 0.04 |   |   | $ | 6,775 |   |   |   | 24,047 |   |   | $ | 0.28 |   |

|                                    | For the Six Months Ended October 31, |   |
|-----------------------------------------|--------------------------------------|--------|
| In thousands                            |                                 | 2009   |   |   | 2008 |   |
| Beginning balance                       |                                 | $      | 2,815 |   |   | $ | 2,327 |   |
| Warranties issued in the current period |                                 |   | 3,253 |   |   |   | 2,552 |   |
| Reductions for costs incurred           |                                 |   | (2,880 | ) |   |   | (2,594 | ) |
| Impact of business acquisitions         |                                 |   | --- |   |   |   | 755 |   |
| Impact of business dispositions         |                                 |   | (574 | ) |   |   | --- |   |
| Ending balance                          |                                 | $      | 2,614 |   |   | $ | 3,040 |   |

----

|                                 |   | For the Fiscal QuartersEnded October 31, |   |   | For the Six MonthsEnded October 31, |   |
|--------------------------------------|--------|------------------------------------------|--------|--------|-------------------------------------|--------|
|  In thousands                   |   | 2009                                     |   |   | 2008                                |   |   | 2009 |   |   | 2008 |   |
| Service cost                         |   | $                                        | ---    |   |                                | $      | 597 |   |   | $ | --- |   |   | $ | 1,194 |   |
| Interest cost                        |   |                                     | 1,699  |   |                                |   | 1,770 |   |   |   | 3,398 |   |   |   | 3,540 |   |
| Expected return on plan assets       |   |                                     | (1,316 | )      |                                |   | (1,710 | ) |   |   | (2,632 | ) |   |   | (3,420 | ) |
| Amortization of:                     |   |                                     |   |   |                                |   |   |   |   |   |   |   |   |   |   |   |
|    Prior service cost |   |                                     | ---    |   |                                |   | 73 |   |   |   | --- |   |   |   | 146 |   |
|    Actuarial loss     |   |                                     | 153    |   |                                |   | 253 |   |   |   | 306 |   |   |   | 506 |   |
| Net periodic benefit cost            |   | $                                        | 536    |   |                                | $      | 983 |   |   | $ | 1,072 |   |   | $ | 1,966 |   |

----

|                                                    |                            |   | Liabilities      |
|---------------------------------------------------------|---------------------------------|--------|------------------|
|  In thousands                                      |  Balance Sheet Location    |   | October 31, 2009 |   |   | April 30, 2009 |   |
| Derivatives designated as hedging instruments:          |                            |   |             |   |   |   |   |
|     Interest rate swap arrangements | Other accrued liabilities  |   | $                | 996 |   |   | $ | 1,181 |   |

|      In thousands                                                                           |   | For the Fiscal Quarter Ended October 31, 2009 |   |   | For the Six Months Ended October 31, 2009 |   |
|----------------------------------------------------------------------------------------------------------------------|--------|-----------------------------------------------|--------|--------|-------------------------------------------|--------|
| Loss recognized in Accumulated Other Comprehensive Loss before tax effect                                            |   | $                                             | 164    |   |                                      | $      | 333 |   |
| Loss reclassified from Accumulated Other Comprehensive Loss to Interest Expense   (effective portion) |   | $                                             | 277    |   |                                      | $      | 518 |   |

|   In thousands       |   | Total  |   |   | Quotedprices inactivemarkets(Level 1) |    | Significantotherobservableinputs(Level 2) |   |   | Significantunobservableinputs(Level 3) |   |
|--------------------------------|--------|--------|--------|--------|---------------------------------------|---------|-------------------------------------------|--------|--------|----------------------------------------|--------|
| Interest rate swap agreements  |   | $      | (996   | )      |                                  | $  | ---                                       |   |   | $                                      | (996   | ) |   |  $ | --- |   |
| Available for sale investments |   |   | 3,588  |   |                                  |    | 3,588                                     |   |   |                                   | ---    |   |   |   | --- |   |
|     Total  |   | $      | 2,592  |   |                                  | $       | 3,588                                     |   |   | $                                      | (996   | ) |   |  $ | --- |   |

----

|                                              |   | For the Fiscal Quarters EndedOctober 31, |    |   | For the Six Months EndedOctober 31, |   |
|---------------------------------------------------|--------|------------------------------------------|---------|--------|-------------------------------------|--------|
| In thousands                                      |   | 2009                                     |    |   | 2008                                |   |   | 2009 |   |   | 2008 |   |
| Revenue from discontinued operations              |   | $                                        | 1,386   |   |                                | $      | 550 |   |   | $ | 5,973 |   |   | $ | 550 |   |
| Pretax (loss) income from discontinued operations | $      | (500                                     | )  |   | $                                   | 187    |   |   | $ | (1,080 | )  |   | $ | 187 |   |

----

|  In thousands                                 |   | September 1, 2009 |   |
|----------------------------------------------------|--------|-------------------|--------|
| Assets:                                            |   |              |   |
| Accounts receivable, net                           |   | $                 | 3,069  |   |
| Inventories                                        |   |              | 3,848  |   |
| Prepaid and other assets                           |   |              | 66     |   |
|      Total current assets |   |              | 6,983  |   |
| Property, plant and equipment, net                 |   |              | 1,336  |   |
|      Total assets         |   | $                 | 8,319  |   |
| Liabilities:                                       |   |              |   |   |
| Accounts payable                                   |   | $                 | 1,142  |   |
| Accrued compensation and benefits                  |   |              | 488    |   |
| Other accrued liabilities                          |   |              | 1,577  |   |
| Other liabilities                                  |   |              | 229    |   |
|      Total liabilities    |   | $                 | 3,436  |   |
| Net assets                                         |   | $                 | 4,883  |   |

|                                       |   | For the Fiscal Quarters EndedOctober 31, |   |   | For the Six Months EndedOctober 31, |   |
|--------------------------------------------|--------|------------------------------------------|--------|--------|-------------------------------------|--------|
| In thousands                               |   | 2009                                     |   |   | 2008                                |   |   | 2009 |   |   | 2008 |   |
| Revenue from discontinued operations       |   | $                                        | 5,362  |   |                                | $      | 9,329 |   |   | $ | 13,901 |   |   | $ | 18,698 |   |
| Pretax income from discontinued operations |   | $                                        | 228    |   |                                | $      | 48 |   |   | $ | 634 |   |   | $ | 106 |   |

|  In thousands                                 |   | September 30, 2009 |   |
|----------------------------------------------------|--------|--------------------|--------|
| Assets:                                            |   |               |   |
| Accounts receivable, net                           |   | $                  | 4,413  |   |
| Inventories                                        |   |               | 4,579  |   |
| Prepaid and other assets                           |   |               | 174    |   |
|      Total current assets |   |               | 9,166  |   |
| Property, plant and equipment, net                 |   |               | 720    |   |
| Other long-term assets                             |   |               | 60     |   |
|      Total assets         |   | $                  | 9,946  |   |
| Liabilities:                                       |   |               |   |   |
| Accounts payable                                   |   | $                  | 1,332  |   |
| Accrued compensation and benefits                  |   |               | 130    |   |
| Other accrued liabilities                          |   |               | 146    |   |
|      Total liabilities    |   | $                  | 1,608  |   |
| Net assets                                         |   | $                  | 8,338  |   |

----

|                                     |   | For the Fiscal Quarters EndedOctober 31, |   |    | For the Six Months EndedOctober 31, |   |
|------------------------------------------|--------|------------------------------------------|--------|---------|-------------------------------------|--------|
| In thousands                             |   | 2009                                     |   |    | 2008                                |   |   | 2009 |   |   | 2008 |   |
| Revenue from discontinued operations     |   | $                                        | 659    |    |                                | $      | 1,326 |   |   | $ | 1,234 |   |   | $ | 2,650 |   |
| Pretax loss from discontinued operations |   | $                                        | (335   | )  |                                | $      | (493 | )  |   | $ | (380 | )  |   | $ | (577 | ) |

----

| Twelve Month Period Ended    | Pre-Amendment Covenant | Amended Covenant |
|------------------------------|------------------------|------------------|
| October 31, 2009             | Maximum 3.75:1         | Maximum 3.50:1   |
| January 31, 2010             | Maximum 3.25:1         | Maximum 3.00:1   |
| April 30, 2010               | Maximum 3.25:1         | Maximum 3.00:1   |
| July 31, 2010 and thereafter | Maximum 3.00:1         | Maximum 3.00:1   |

| Twelve Month Period Ended       | Pre-Amendment Covenant | Amended Covenant |
|---------------------------------|------------------------|------------------|
| October 31, 2009                | Minimum 2.00:1         | Minimum 1.50:1   |
| January 31, 2010                | Minimum 2.25:1         | Minimum 1.50:1   |
| April 30, 2010                  | Minimum 2.75:1         | Minimum 2.25:1   |
| July 31, 2010                   | Minimum 3.00:1         | Minimum 2.50:1   |
| October 31, 2010 and thereafter | Minimum 3.00:1         | Minimum 3.00:1   |

----

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

| ·   | expected financial condition, future earnings, levels of growth, or other measures of financial performance, or the future size of market segments or geographic markets; |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | economic conditions; |
|--------------------|----------------------|

| ·   | planned cost reductions; |
|--------------------|--------------------------|

| ·   | future cash flows and uses of cash and debt reduction strategies; |
|--------------------|-------------------------------------------------------------------|

| ·   | prospective product developments and business growth opportunities, as well as competitor product developments; |
|--------------------|-----------------------------------------------------------------------------------------------------------------|

| ·   | demand for Gerber's products and services; |
|--------------------|--------------------------------------------|

| ·   | methods of and costs associated with potential geographic expansion; |
|--------------------|----------------------------------------------------------------------|

| ·   | regulatory and market developments and the impact of such developments on future operating results; |
|--------------------|-----------------------------------------------------------------------------------------------------|

| ·   | potential impacts from credit market risk; |
|--------------------|--------------------------------------------|

| ·   | future effective income tax rates; |
|--------------------|------------------------------------|

| ·   | the outcome of contingencies; |
|--------------------|-------------------------------|

| ·   | the availability and cost of raw materials; and |
|--------------------|-------------------------------------------------|

| ·   | pension plan assumptions and future contributions. |
|--------------------|----------------------------------------------------|

----

----

|                   |   | For the Fiscal Quarters EndedOctober 31, |    |   | For the Six Months EndedOctober 31, |   |
|------------------------|--------|------------------------------------------|---------|--------|-------------------------------------|--------|
| In thousands           |   | 2009                                     |    |   | 2008                                |   |   | Percent Change |   |   | 2009 |   |   | 2008 |   |   | Percent Change |   |
| Equipment and software |   | $                                        | 29,880  |   |                                | $      | 43,611 |   |   |   | (31.5 | %) |   | $ | 55,729 |   |   | $ | 84,983 |   |   |   | (34.4 | %) |
| Aftermarket supplies   |   |                                     | 73,666  |   |                                |   | 80,149 |   |   |   | (8.1 | %) |   |   | 141,581 |   |   |   | 167,967 |   |   |   | (15.7 | %) |
| Service                |   |                                     | 16,614  |   |                                |   | 18,793 |   |   |   | (11.6 | %) |   |   | 33,438 |   |   |   | 37,768 |   |   |   | (11.5 | %) |
| Total revenue          |   | $                                        | 120,160 |   |                                | $      | 142,553 |   |   |   | (15.7 | %) |   | $ | 230,748 |   |   | $ | 290,718 |   |   |   | (20.6 | %) |

|  In thousands                                   |   | October 31,2009 |   |   | April 30,2009 |   |
|------------------------------------------------------|--------|-----------------|--------|--------|---------------|--------|
| Backlog:                                             |   |            |   |   |          |   |
|    Sign Making and Specialty Graphics |   | $               | 1,532  |   |          | $      | 1,636 |   |
|    Apparel and Flexible Materials     |   |            | 23,186 |   |          |   | 21,800 |   |
|    Ophthalmic Lens Processing         |   |            | 650    |   |          |   | 1,200 |   |
|                                                 |   | $               | 25,368 |   |          | $      | 24,636 |   |

----

|                |   | For the Fiscal Quarters EndedOctober 31, |   | For the Six Months EndedOctober 31, |    |
|---------------------|--------|------------------------------------------|--------|-------------------------------------|--------------|
| In thousands        |   | 2009                                     |   | 2008                                |         | Percent Change |   | 2009 |   | 2008 |   | Percent Change |   |
| Gross profit        |   | $                                        | 35,220 |                                | $            | 41,405 |   | (14.9 | %) | $ | 67,247 |   | $ | 81,749 |   | (17.7 | %) |
| Gross profit margin |   |                                     | 29.3   | %                                   |         | 29.0 | % |   |   |   | 29.1 | % |   | 28.1 | % |   |   |

|                                         |   | For the Fiscal Quarters EndedOctober 31, |   | For the Six Months EndedOctober 31, |    |
|----------------------------------------------|--------|------------------------------------------|--------|-------------------------------------|--------------|
| In thousands                                 |   | 2009                                     |   | 2008                                |         | PercentChange |   | 2009 |   | 2008 |   | PercentChange |   |
| Selling, general and administrative expenses |   | $                                        | 27,817 |                                | $            | 30,155 |   | (7.8 | %) | $ | 51,967 |   | $ | 62,718 |   | (17.1 | %) |
| Percentage of revenue                        |   |                                     | 23.1   | %                                   |         | 21.2 | % |   |   |   | 22.5 | % |   | 21.6 | % |   |   |

----

|                     |   | For the Fiscal Quarters EndedOctober 31, |   |   | For the Six Months EndedOctober 31, |    |
|--------------------------|--------|------------------------------------------|--------|--------|-------------------------------------|--------------|
| In thousands             |   | 2009                                     |   |   | 2008                                |         |   | PercentChange |   |   | 2009 |   |   | 2008 |   |   | PercentChange |   |
| Research and development |   | $                                        | 4,532  |   |                                | $            | 5,698 |   |   |   | (20.5 | %) |   | $ | 8,960 |   |   | $ | 11,931 |   |   |   | (24.9 | %) |
| Percentage of revenue    |   |                                     | 3.8    | %      |                                |         | 4.0 | % |   |   |   |   |   |   | 3.9 | % |   |   | 4.1 | % |   |   |   |   |

|                        |   | For the Fiscal Quarters EndedOctober 31, |   |    | For the Six Months EndedOctober 31, |   |
|-----------------------------|--------|------------------------------------------|--------|---------|-------------------------------------|--------|
| In thousands                |   | 2009                                     |   |    | 2008                                |   |   | 2009 |   |   | 2008 |   |
| Other income (expense), net |   | $                                        | (394   | )  |                                | $      | (412 | )  |   | $ | (1,399 | )  |   | $ | (537 | )  |

|                                           |   | For the Fiscal Quarters EndedOctober 31, |   | For the Six Months EndedOctober 31, |   |
|------------------------------------------------|--------|------------------------------------------|--------|-------------------------------------|--------|
| In thousands                                   |   | 2009                                     |   |                                | 2008   |   |   | PercentChange |   |   | 2009 |   |   | 2008 |   |   | PercentChange |   |
| Interest expense                               |   | $                                        | 918    |                                |   | $ | 748 |   |   |   | 22.7 | % |   | $ | 1,860 |   |   | $ | 1,287 |   |   |   | 44.5 | % |
| Weighted-average credit facility interest rate |   |                                     | 7.1    | %                                   |   |   | 5.4 | % |   |   |   |   |   |   | 7.0 | % |   |   | 5.3 | % |   |   |   |   |

----

|               |   | For the Fiscal QuartersEnded October 31, |   |   | For the Six Months EndedOctober 31, |   |
|--------------------|--------|------------------------------------------|--------|--------|-------------------------------------|--------|
|               |   | 2009                                     |   |   | 2008                                |   |   | 2009 |   |   | 2008 |   |
| Effective tax rate |   |                                     | (24.0  | %)     |                                |   | (44.9 | %) |   |   | (0.5 | %) |   |   | (34.4 | %) |

| Operating Segment                  | Principal Business                             |
|------------------------------------|------------------------------------------------|
| Sign Making and Specialty Graphics | Gerber Scientific Products ("GSP") and Spandex |
| Apparel and Flexible Materials     | Gerber Technology                              |
| Ophthalmic Lens Processing         | Gerber Coburn                                  |

----

|                    |   | For the Fiscal Quarters Ended October 31, |   |
|-------------------------|--------|-------------------------------------------|--------|
|                    |   | 2009                                      |   |   | 2008 |   |
| In thousands            |   | GSP                                       |   |   | Spandex |   |   | Total |   |   | GSP |   |   | Spandex |   |   | Total |   |
| Revenue                 |   | $                                         | 13,375 |   |   | $ | 55,689 |   |   | $ | 69,064 |   |   | $ | 18,954 |   |   | $ | 62,581 |   |   | $ | 81,535 |   |
| Operating (loss) income |   | $                                         | (1,240 | ) |   | $ | 3,492 |   |   | $ | 2,252 |   |   | $ | 150 |   |   | $ | 2,675 |   |   | $ | 2,825 |   |

|                    |   | For the Six Months Ended October 31, |   |
|-------------------------|--------|--------------------------------------|--------|
|                    |   | 2009                                 |   |   | 2008 |   |
| In thousands            |   | GSP                                  |   |   | Spandex |   |   | Total |   |   | GSP |   |   | Spandex |   |   | Total |   |
| Revenue                 |   | $                                    | 24,262 |   |   | $ | 108,827 |   |   | $ | 133,089 |   |   | $ | 33,519 |   |   | $ | 131,692 |   |   | $ | 165,211 |   |
| Operating (loss) income |   | $                                    | (2,462 | ) |   | $ | 6,525 |   |   | $ | 4,063 |   |   | $ | (1,215 | ) |   | $ | 6,128 |   |   | $ | 4,913 |   |

|                     |   | For the Fiscal Quarters EndedOctober 31, |   |   | For the Six Months EndedOctober 31, |   |
|--------------------------|--------|------------------------------------------|--------|--------|-------------------------------------|--------|
| In thousands             |   | 2009                                     |   |   | 2008                                |   |   | 2009 |   |   | 2008 |   |
| Revenue                  |   | $                                        | 37,094 |   |                                | $      | 45,382 |   |   | $ | 72,154 |   |   | $ | 94,331 |   |
| Segment operating income |   | $                                        | 3,298  |   |                                | $      | 4,929 |   |   | $ | 7,457 |   |   | $ | 8,595 |   |

----

|                     |   | For the Fiscal Quarters EndedOctober 31, |   |   | For the Six Months EndedOctober 31, |   |
|--------------------------|--------|------------------------------------------|--------|--------|-------------------------------------|--------|
| In thousands             |   | 2009                                     |   |   | 2008                                |   |   | 2009 |   |   | 2008 |   |
| Revenue                  |   | $                                        | 14,002 |   |                                | $      | 15,636 |   |   | $ | 25,505 |   |   | $ | 31,176 |   |
| Segment operating income |   | $                                        | 1,625  |   |                                | $      | 1,773 |   |   | $ | 2,320 |   |   | $ | 1,888 |   |

|               |   | For the Fiscal Quarters EndedOctober 31, |   |   | For the Six Months EndedOctober 31, |   |
|--------------------|--------|------------------------------------------|--------|--------|-------------------------------------|--------|
| In thousands       |   | 2009                                     |   |   | 2008                                |   |   | 2009 |   |   | 2008 |   |
| Operating expenses |   | $                                        | 4,304  |   |                                | $      | 3,975 |   |   | $ | 7,520 |   |   | $ | 8,296 |   |

----

|  In thousands, except ratio amounts                  |   | October 31,2009 |    |   | April 30,2009 |   |
|-----------------------------------------------------------|--------|-----------------|---------|--------|---------------|--------|
| Cash and cash equivalents                                 |   | $               | 14,443  |   |          | $      | 10,313 |   |
| Working capital                                           |   | $               | 87,808  |   |          | $      | 92,839 |   |
| Total debt                                                |   | $               | 51,000  |   |          | $      | 73,500 |   |
| Net debt (total debt less cash and cash equivalents) |   | $               | 36,557  |   |          | $      | 63,187 |   |
| Shareholders' equity                                      |   | $               | 166,815 |   |          | $      | 148,302 |   |
| Total capital (net debt plus shareholders' equity)        |   | $               | 203,372 |   |          | $      | 211,489 |   |
| Current ratio                                             |   | 1.96:1          |    |   | 2.02:1        |   |
| Net debt-to-total capital ratio                           |   |            | 18.0    | %      |          |   | 29.9 | % |

----

|                                                   | For the Six Months Ended October 31, |   |
|--------------------------------------------------------|--------------------------------------|--------|
| In thousands                                           |                                 | 2009   |   |   | 2008 |   |
| Cash flows provided by operating activities            |                                 | $      | 15,754 |   |   | $ | 2,941 |   |
| Cash flows provided by (used for) investing activities |                                 | $      | 8,499 |   |   | $ | (38,081 | ) |
| Cash flows (used for) provided by financing activities |                                 | $      | (22,050 | )  |   | $ | 41,637 |   |

----

| Twelve Month Period Ended    | Pre-Amendment Covenant | Amended Covenant |
|------------------------------|------------------------|------------------|
| October 31, 2009             | Maximum 3.75:1         | Maximum 3.50:1   |
| January 31, 2010             | Maximum 3.25:1         | Maximum 3.00:1   |
| April 30, 2010               | Maximum 3.25:1         | Maximum 3.00:1   |
| July 31, 2010 and thereafter | Maximum 3.00:1         | Maximum 3.00:1   |

| Twelve Month Period Ended       | Pre-Amendment Covenant | Amended Covenant |
|---------------------------------|------------------------|------------------|
| October 31, 2009                | Minimum 2.00:1         | Minimum 1.50:1   |
| January 31, 2010                | Minimum 2.25:1         | Minimum 1.50:1   |
| April 30, 2010                  | Minimum 2.75:1         | Minimum 2.25:1   |
| July 31, 2010                   | Minimum 3.00:1         | Minimum 2.50:1   |
| October 31, 2010 and thereafter | Minimum 3.00:1         | Minimum 3.00:1   |

----

| Covenant                                           | Requirement    | Actual as of October 31, 2009 |
|----------------------------------------------------|----------------|-------------------------------|
| Total Funded Debt to Consolidated EBITDA           | Maximum 3.50:1 | 2.97:1                        |
| Consolidated EBIT to Consolidated Interest Expense | Minimum 1.50:1 | 2.11:1                        |
| Asset Coverage Ratio                               | At least 1.0:1 | 1.54:1                        |

----

ITEM 3.

ITEM 4.

----

PART II 

ITEM 1A.

ITEM 2

| Period                                           |   | (a)TotalNumberof Shares(or Units)Purchased |   |   | (b)AveragePricePaid perShare(or Unit) |   | (c)Total Number ofShares (or Units)Purchased as Partof PubliclyAnnounced Plansor Programs | (d)MaximumNumber (orApproximateDollar Value)of Shares (or Units)that May Yet BePurchased Under thePlans or Program |
|--------------------------------------------------|--------|--------------------------------------------|--------|--------|---------------------------------------|--------|-------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------|
| August 1, 2009 – August 31, 2009           |   |                                       | ---    |   |                                  |   | ---                                                                                       |                                                                                                               | Not applicable | Not applicable |
| September 1, 2009 – September 30, 2009 (1) |   |                                       | 20,096 |   |                                  | $      | 6.00                                                                                      |                                                                                                               | Not applicable | Not applicable |
| October 1, 2009 – October 31, 2009         |   |                                       | ---    |   |                                  |   | ---                                                                                       |                                                                                                               | Not applicable | Not applicable |
|                                             |   |                                       | 20,096 |   |                                  | $      | 6.00                                                                                      |                                                                                                               | Not applicable | Not applicable |

ITEM 4.

| (a)   | Gerber Scientific, Inc. held its fiscal 2009 annual meeting of stockholders on September 17, 2009. |
|-----------------|----------------------------------------------------------------------------------------------------|

----

| Nominees                  |   | Votes For |       |   | Votes Withheld |   |
|---------------------------|--------|-----------|------------|--------|----------------|--------|
| Donald P. Aiken           |   |      | 21,965,679 |   |           |   | 452,226 |   |
| Marc T. Giles             |   |      | 21,985,881 |   |           |   | 432,078 |   |
| Edward G. Jepsen          |   |      | 21,398,682 |   |           |   | 1,019,223 |   |
| Randall D. Ledford, Ph.D. |   |      | 22,014,680 |   |           |   | 403,225 |   |
| John R. Lord              |   |      | 21,434,009 |   |           |   | 983,899 |   |
| Javier Perez              |   |      | 21,287,056 |   |           |   | 262,594 |   |
| Carole F. St. Mark        |   |      | 21,344,205 |   |           |   | 1,073,700 |   |
| W. Jerome Vereen          |   |      | 21,326,781 |   |           |   | 1,091,124 |   |

|                                                                          |   | Votes For |       |   | Votes Against |   |   | Votes Abstain |   |
|-------------------------------------------------------------------------------|--------|-----------|------------|--------|---------------|--------|--------|---------------|--------|
| Ratification of the appointment of PricewaterhouseCoopers LLP for fiscal 2010 |   |      | 22,327,404 |   |          |   | 60,893 |          |   |   | 29,609 |   |

|                                                                                                                               |   | Votes For |       |   | Votes Against |   |      | Votes Abstain |   |
|------------------------------------------------------------------------------------------------------------------------------------|--------|-----------|------------|--------|---------------|--------|-----------|---------------|--------|
| Amendment of the Gerber Scientific, Inc. 2006 Omnibus Incentive Plan to increase shares available for issuance by 1,250,000 shares |   |      | 10,756,636 |   |          |   | 6,933,268 |          |   |   | 53,147 |   |

ITEM 5

----

| ·   | the name and address of such persons; |
|--------------------|---------------------------------------|

| ·   | the class or series and number of shares of Gerber’s capital stock which are owned beneficially and of record by such persons; |
|--------------------|--------------------------------------------------------------------------------------------------------------------------------------|

| ·   | a description of any agreement, arrangement or understanding with respect to the nomination or proposal between or among the shareholder, any such beneficial owner, and their respective affiliates or associates or others acting in concert with such persons; |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | a description of any agreement, arrangement or understanding (including any derivative, hedging, or similar position, transaction or activity) that has been entered into by or on behalf of the shareholder and beneficial owner the effect or intent of which is to mitigate loss to, manage risk or benefit of share price changes for, or increase or decreasethe voting power of, such shareholder or beneficial owner, with respect to Gerber’s shares of stock; |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | a representation that the shareholder intends to appear in person or by proxy at the meeting to propose such business or nomination; and |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | a representation as to whether such persons intend or are part of a group which intends to deliver a proxy statement or form of proxy to holders of at least the percentage of Gerber’s capital stock required to approve the proposal or elect the nominee, or to otherwise solicit proxies or votes. |
|--------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

ITEM 6. 

| Exhibit Number |   | Description |
|----------------|--------|-------------|
|           |   |        |
|           | 3.2    |        | Amendment to Amended and Restated By-Laws of Gerber Scientific, Inc., filed herewith. |
|           |   |        |   |
|           | 10.1   |        | Gerber Scientific, Inc. 2006 Omnibus Incentive Plan, as amended (incorporated herein by reference to Exhibit 10.1 to Gerber Scientific, Inc.’s Current Report on Form 8-K filed on September 23, 2009). |
|           |   |        |   |
|           | 31.1   |        | Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, filed herewith. |
|           |   |        |   |
|           | 31.2   |        | Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, filed herewith. |
|           |   |        |   |
|           | 32     |        | Certification of Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(b) or 15d-14(b) under the Securities Exchange Act of 1934 and to 18 U.S.C. 1350, filed herewith. |

----

SIGNATURE

|             | GERBER SCIENTIFIC, INC.                                                                                                                              |
|------------------|------------------------------------------------------------------------------------------------------------------------------------------------------|
| December 8, 2009 | By:                                                                                                                                                  |                    /s/    John J. Krawczynski       |
|             |  John J. KrawczynskiVice President, Chief Accounting Officer and Corporate Controller(Duly Authorized Officer and Principal Accounting Officer) |

----

Exhibit Index 

| Exhibit Number |   | Description |
|----------------|--------|-------------|
|           |   |        |
|           | 3.2    |        | Amendment to Amended and Restated By-Laws of Gerber Scientific, Inc., filed herewith. |
|           |   |        |   |
|           | 10.1   |        | Gerber Scientific, Inc. 2006 Omnibus Incentive Plan, as amended (incorporated herein by reference to Exhibit 10.1 to Gerber Scientific, Inc.’s Current Report on Form 8-K filed on September 23, 2009). |
|           |   |        |   |
|           | 31.1   |        | Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, filed herewith. |
|           |   |        |   |
|           | 31.2   |        | Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, filed herewith. |
|           |   |        |   |
|           | 32     |        | Certification of Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(b) or 15d-14(b) under the Securities Exchange Act of 1934 and to 18 U.S.C. 1350, filed herewith. |

----